PharmaCyte Biotech Officers to Attend Annual Meeting of the American Society of Clinical Oncology Biotech Investing
Marina Biotech Announces Resignation of Chairman, President and Chief Executive Officer J. Michael French Biotech Investing
AmpliPhi Biosciences to be Granted European Patent Covering the Use of Phage Therapy to Resensitize Bacterial Infections To Antibiotics Biotech Investing
Viamet Receives Fast Track Designation from the FDA for VT-1129 for the Treatment of Cryptococcal Meningitis Biotech Investing
Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering Biotech Investing
Jubilant Biosys Enters into Exclusive out-Licensing Agreement with Checkpoint Therapeutics for Novel BET Inhibitors Biotech Investing
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) as Consolidation Treatment in Post-Transplant Hodgkin Lymphoma Biotech Investing
22nd Century Presents at Hofstra Northwell School of Medicine; Reveals New Initiative to Engage Health Care Professionals Biotech Investing
EnWave Announces First Quarterly Positive Net Income and Reports Consolidated Interim Financial Results for the Second Quarter Fiscal Year 2016 Biotech Investing
